Woman with Tardive Dyskinesia Loses Case against Reglan
Wyeth and Schwarz Pharma, the manufacturers of Reglan, won a recent case regarding a woman in West Virginia who developed tardive dyskinesia and other side effects from taking a generic version of the drug. The woman accused Wyeth and Schwarz Pharma of manufacturing the drug that caused her condition. The company was exempt from liability given that a different manufacturer produced the generic drug the woman was taking. The woman alleged that she was prescribed the Pharma version of the drug, but given a generic version by her pharmacy. It is unknown whether or not the woman will pursue the lawsuit with the manufacturers of the generic drug.
Reglan, also known as Metoclopramide, is used to treat heartburn, acid reflux and Gastro-Esophageal Reflux Disease (GERD). Studies have shown that 27-29 percent of long-term users of Reglan develop tardive dyskinesia; an untreatable condition characterized by involuntary, repetitive and purposeless movements such as rapid blinking, arm and leg jerking, and lip smacking. The syndrome is often devastating and permanent, affecting victims’ emotions, social interaction, mental state and vocation.
Another serious side effect of Reglan is Neuroleptic Malignant Syndrome (NMS). Symptoms develop within the first two weeks of taking the drug and include sweating, muscular rigidity, high fever, hyperthermia and unstable blood pressure, pulse or heartbeat. The condition is often fatal.
If you are taking Reglan or any generic versions of the drug and experience any of these symptoms, contact your doctor immediately. Then call a skilled St. Louis drug injury attorney at Page Cagle. Contact our offices at (866) 620-5757 to discuss your case in a free consultation.
Source article: http://www.lawyersandsettlements.com/articles/13189/reglan-side-effects-tardive-dyskinesia-22.html
